0001209191-19-003079.txt : 20190109
0001209191-19-003079.hdr.sgml : 20190109
20190109165430
ACCESSION NUMBER: 0001209191-19-003079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190107
FILED AS OF DATE: 20190109
DATE AS OF CHANGE: 20190109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Thomas Patrick
CENTRAL INDEX KEY: 0001410514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 19518642
MAIL ADDRESS:
STREET 1: 60 WESTVIEW STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-07
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001410514
Kelly Thomas Patrick
C/O DECIPHERA PHARMACEUTICALS, INC.
500 TOTTEN POND ROAD
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
Common Stock
2019-01-07
4
M
0
5000
1.89
A
5000
D
Common Stock
2019-01-07
4
S
0
5000
25.18
D
0
D
Stock Option (Right to Buy)
1.89
2019-01-07
4
M
0
5000
0.00
D
2025-12-17
Common Stock
5000
168008
D
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.39. The Reporting Person undertakes to provide to the Issuer, any
security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 16 equal installments over a 4-year period following the vesting commencement date of 2/23/2015, subject to continued service through such dates.
/s/ Thomas P. Kelly
2019-01-09